What role does apoptosis play in progression of renal disease?

Current Opinion in Nephrology and Hypertension

Volumn 5, Issue 4, 1996, Pages 369-374

  Savill, John ^a,b   Mooney, Andrew ^a   Hughes, Jeremy ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CELL COUNT; CELL LOSS; DISEASE COURSE; GLOMERULONEPHRITIS; HUMAN; KIDNEY CELL; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS; GLOMERULONEPHRITIS; HOMEOSTASIS; HUMANS; INFLAMMATION; KIDNEY; KIDNEY DISEASES; POLYCYSTIC KIDNEY DISEASES; REFERENCE VALUES;

EID: 0030000059     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199607000-00014     Document Type: Review

References (62)

1. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with widespread implications in tissue kinetics. Br J Cancer 1972, 26:239-257.
2. Wyllie AH, Kerr JFR, Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 1980, 68:251-306.
3. Martin SJ, Green DR: Protease activation during apoptosis: death by a thousand cuts? Cell 1995, 82:349-352.
4. Savill J: Apoptosis and the kidney. J Am Soc Nephrol 1994, 5:12-21.
5. Savill J: Apoptosis and renal injury. Curr Opin Nephrol Hypertens 1995, 4:263-269.
6. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981, 241:F85-F93.
7. Zuchelli P, Zuccala A, Borghi M, Fusaroli M, Sasdelli M, Stallone C, Sanna G, Gaggi R: Long term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 1992, 42:452-458.
8. Eddy AA: Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 1994, 5:1273-1287.
9. Ong ACM, Fine LG: Loss of glomerular function and tubulointerstitial fibrosis: cause or effect? Kidney Int 1994, 45:345-351.
10. Abboud HE: Nephrology forum: growth factors in glomerulonephritis. Kidney Int 1993, 43:252-267.
11. Johnson R: The glomerular response to injury: progression or resolution? Kidney Int 1994, 45:1769-1782.
12. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 1994, 331:1286-1292.
13. Pabst R, Sterzel RB: Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis. Kidney Int 1983, 24:626-631.
14. Striker LJ, Peten EP, Elliot SJ, Doi T, Striker GE: Mesangial cell turnover: effect of heparin and peptide growth factors. Lab Invest 1991, 64:446-456.
15. Gobé GC, Axelsen RA: Genesis of renal tubular atrophy in experimental hydronephrosis in the rat: role of apoptosis. Lab Invest 1987, 56:273-282.
16. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J: Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 1994, 94:2105-2116.
17. Takemura T, Murakami K, Miyazato H, Yagi K, Yoshioka K: Expression of Fas antigen and Bcl-2 in human glomerulonephritis. Kidney Int 1995, 48:1886-1892.
18. Gonzalez-Cuadrado S, Ortiz A, Karp S, Li S, Cizman B, Lopez-Armada MJ, Madaio M, Egido J, Neilson EG: The Fas ligand (FasL)-Fas (CD95) system in the kidney [Abstract]. J Am Soc Nephrol 1994, 5:748.
19. de Lajarte AS, Brun P, Baudouin V, Paris R, Loirat C, Peuchmaur M: Detection of TIA-1 cytotoxic T-lymphocytes and epithelial apoptotic cells in renal allograft biopsies. Transplant Proc 1995, 27:2474-2475.
20. Liu Z-H, Striker GE, Stetler-Stevenson M, Fukushima P, Stahl PD, Striker LJ: Tumor necrosis factor-a and IL-1α induce apoptosis in glomerular mesangial cells but not in endothelial cells [Abstract]. J Am Soc Nephrol 1995, 6:771.
21. Sugiyama H, Kashihara N, Yamasaki Y, Sekikawa T, Okamoto K, Kanoa K, Maeshima Y, Makino H, Ota Z: Reactive oxygen species induce apoptosis in cultured mesangial cells [Abstract]. J Am Soc Nephrol 1994, 5:796.
22. Bódi I, Abraham AA, Kimmel PL: Apoptosis in human immunodeficiency virus-associated nephropathy. Am J Kidney Dis 1995, 26:286-291.
23. Schumer M, Sawczuk JS, Colombel MC, Gobé G, Connor J, O'Toole KM, Olsson CA, Wise GJ, Buttyan R: Morphologic, biochemical and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 1992, 140:831-838.
24. Duvall E, Wyllie AH: Death and the cell. Immunol Today 1986, 7:115-119.
25. Vaux DL, Haecker G, Strasser A: An evolutionary perspective on apoptosis. Cell 1994, 76:777-779.
26. Raff MC: Social controls on cell survival and cell death. Nature 1992, 356:397-400.
27. Harrington EA, Bennett MR, Fanidi A, Evan GI: Control of c-Myc-induced apoptosis in fibroblasts by cytokines. EMBO J 1994, 13:3286-3294.
28. Barres BA, Hart IK, Coles HSR, Burne JF, Voyvodic JT, Richardson WD, Raff MC: Cell death and control of cell survival in the oligodendrocyte lineage. Cell 1992, 70:31-46.
29. Frish SM, Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994, 124:619-626.
30. Ruoslahti E, Reed JC: Anchorage dependence, integrins, and apoptosis. Cell 1994, 77:477-478.
31. 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci USA 1995, 92:6161-6165.
32. Coles HSR, Burne JF, Raff MC: Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 1993, 118:777-784.
33. Kennedy WA, Buttyan R, Sawczuk IS: Epidermal growth factor suppresses renal tubular apoptosis following ureteral obstruction [Abstract]. J Am Soc Nephrol 1993, 4:738.
34. Mooney A, Savill J: Insulin-like growth factor-I is a candidate mesangial cell survival factor, inhibiting mesangial cell apoptosis in vitro [Abstract]. J Am Soc Nephrol 1995, 6:877.
35. Sugiyama H, Kashihara N, Sekikawa T, Maeshima Y, Okamoto K, Kanao K, Makino H, Ota Z: Cell-matrix interactions modulate mesangial cell apoptosis [Abstract]. J Am Soc Nephrol 1995, 6:912.
36. Yao R, Cooper GM: Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 1995, 267:2003-2006.
37. Haimovitz-Friedman A, Balaban N, McLoughlin M, Ehleiter D, Michaeli J, Fuks Z: Protein kinase C mediates basic fibroblastic growth factor protection of endothelial cells against radiation induced apoptosis. Cancer Res 1994, 54:2591-2597.
38. Korsmeyer SJ: Bcl-2: an antidote to programmed cell death. Cancer Surv 1992, 15:150-181.
39. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994, 124:1-6.
40. Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB, Korsmeyer SJ: Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci USA 1995, 92:7834-7838.
41. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993, 75:229-240.
42. Sorenson CM, Rogers SA, Korsmeyer SJ, Hammerman MR: Fulminant metanephric apoptosis and abnormal kidney development in Bcl-2-deficient mice. Am J Physiol 1995, 268:F73-F81. This is an interesting follow-up to [41] using explants of metanephric tissue to demonstrate that the dysplastic kidneys of bcl-2 'knockout' mice arise because of an intrinsic defect in renal development.
43. Rogers SA, Sorenson CM, Hammerman MR: Polypeptide growth factors act as survival factors for developing kidneys from Bcl-2 -/-mice [Abstract]. J Am Soc Nephrol 1995, 6:708.
44. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992, 119:493-501.
45. Wijsman JH, Jonker RR, Keijzer R, Van de Velde CJH, Cornelisse CJ, Van Direndonck JH: A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 1993, 41:7-12.
46. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980, 284:555-556.
47. Iwata M, Myerson D, Torok-Storb B, Zager RA: An evaluation of renal tubular DNA laddering in response to oxygen deprivation and oxidant injury. J Am Soc Nephrol 1994, 5:1307-1313.
48. Ueda N, Walker PD, Hsu S-M, Shah SV: Activation of a 15-kDa endonuclease in hypoxia/reoxygenation injury without morphological features of apoptosis. Proc Natl Acad Sci U S A 1995, 92:7202-7206. This is an important study which not only partly characterized a proximal tubular endonuclease triggered by hypoxia/reperfusion, but also emphasized that elements of the pathway of programmed cell death can be dissociated from the classical morphological changes which define apoptosis (see also [47]).
49. Woo DDL: Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 1995, 333:18-25. A clear and potentially important demonstration of increased apoptosis in human ADPKD.
50. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z: Apoptosis in glomerular sclerosis. Kidney Int 1996, 49:103-111. Important new data are described in detail in this review, which suggest that apoptosis might be the mechanism by which glomerular cells are lost during scarring. A convincing demonstration is given of increased glomerular cell apoptosis in IgA nephropathy and lupus nephritis, which correlated with 'sclerosis score'. Support is provided by studies of remnant kidneys in rats, which showed increased glomerular and tubular cell apoptosis in kidneys undergoing glomerular and interstitial scarring.
51. Chikaraishi T, Ishikura H, Seki T, Koyanagi T, Yoshiki T: DNA nick end labelling of rat renal allografts treated with 15-deoxyspergualin (DSG). Transplant Proc 1995, 27:557-558.
52. Hamada T, Tanimoto A, Iwai S, Fujiwara H, Sasaguri Y: Cytopathological changes induced by cadmium-exposure in canine proximal tubular cells: a cytochemical and ultrastructural study. Nephron 1994, 68:104-111.
53. Cohen JJ: Programmed cell death in the immune system. Adv Immunol 1991, 50:55-85.
54. Wilson PD, Hreniuk D, Gabow PA: Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia. J Cell Physiol 1992, 150:360-369.
55. Du J, Wilson PD: Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am J Physiol 1995, 269:C487-C495.
56. Evan GI, Wyllie AH, Gilbert GS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992, 9:119-128.
57. Ojeda JL, Angeles Ros MA, Icardo JM, Garcia-Porrero JA: Basement membrane alterations during development and regression of tubular cysts. Kidney Int 1990, 37:1270-1280.
58. Schäfer K, Bader M, Gretz N, Oberbäumer I, Bachmann S: Focal overexpression of collagen IV characterises the initiation of epithelial changes in polycystic kidney disease. Exp Nephrol 1994, 2:190-195.
59. Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, Gamble V, Harris PC: The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 1995, 10:151-160. This is a seminal study, but the relevance of polycystin function to apoptosis is, so far, not clear.
60. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N: Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 1995, 47:114-121. This is an elegant study suggesting a major role for apoptosis in resolution of glomerular hypercellularity (see also [16]).
61. Wahl SM: Transforming growth factor β: the good, the bad and the ugly. J Exp Med 1994, 180:1587-1590.
62. Shimizu A, Nakao N, Muroga K, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y: Apoptosis in progression process of experimental crescentic glomerulonephritis [Abstract]. J Am Soc Nephrol 1994, 5:769.